Labcorp reported revenue of USD 2.00 billion for the fourth quarter (Q4) of 2025 and USD 8.88 billion for the full year (FY) 2025. Net earnings attributable to shareholders reached USD 164.7 million for Q4 2025 and USD 876.5 million for FY 2025. Diluted earnings per share $(EPS)$ for Q4 2025 were USD 1.98, while full-year diluted EPS stood at USD 10.46. Adjusted EPS was USD 4.07 for Q4 2025 and USD 16.44 for FY 2025. Adjusted operating income as a percentage of revenue increased by 1.2 percentage points in Q4 2025, primarily driven by organic growth in Diagnostics and Central Labs. The company also recorded gains and losses related to its investments in technology-focused companies and funds, as well as a gain from the sale of its Beacon Laboratory Benefits Solutions business and a charge related to the settlement of certain U.S. pension plan obligations.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Labcorp Holdings Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202602170650PR_NEWS_USPR_____DC89006) on February 17, 2026, and is solely responsible for the information contained therein.